Author

Steffanie S. Braun

University of Miami

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Ashley N. ZunigaiD· 1 shared Claude‐Henry VolmariD· 1 shared Daniel BilbaoiD· 1 shared Efe KaracaiD· 1 shared Emily Victoria AdisiD· 1 shared Gabriela I. Quintana· 1 shared Gulum YenisehirliiD· 1 shared J. William HarbouriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ashley N. ZunigaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Identification of targetable epigenetic vulnerabilities for uveal melanoma

Gulum Yenisehirli, Sebastian Borges, Steffanie S. Braun, Ashley N. Zuniga, Gabriela I. Quintana, Jeffim N. Kuznetsoff, Renata L. Volonterio, Sara Rodríguez, Emily Victoria Adis, Sofia Lopez, James Jarad Dollar, Vasileios Stathias, Claude‐Henry Volmar, Efe Karaca, Shaun P. Brothers, , Stefan Kurtenbach

This study identifies BET inhibition as a promising therapeutic strategy for uveal melanoma by demonstrating its efficacy in reducing metastasis and improving survival in a mouse model.

Cell Death and Disease · Dec 12, 2025Peer-reviewedCancer Biology